Loading...
Publication
Does B Corp Certification Affect the Pharmaceutical Industry?
| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 751.88 KB | Adobe PDF |
Authors
Advisor(s)
Abstract(s)
Este estudo contribui para uma compreensão mais profunda do desenvolvimento sustentável organizacional numa perspetiva dos “stakeholders”, uma questão atual que tem estado mais presente na agenda política das Nações Unidas para 2030.
A investigação estuda em particular as empresas que se submetem a práticas Ambientais, Sociais e de Governação pelo nome de B Corps, com a missão de "Profit for Purpose", de modo a gerar valor juntamente com os seus “stakeholders” e a forma como estas organizações têm um impacto positivo na indústria farmacêutica.
Na presente investigação, foi realizada uma revisão bibliográfica que salienta a importância das práticas de Responsabilidade Social Corporativa nas organizações, utilizando uma amostra de B Corps farmacêuticas na Península Ibérica, como um canal para as organizações compreenderem a forma de operar dentro da indústria farmacêutica, alinhando os seus objetivos de lucro e desenvolvimento sustentável, de modo a criar valor.
Complementando a revisão de literatura, foi realizado um estudo quantitativo com uma série de testes de regressão estatística que procuram compreender como a B Corp e outras variáveis explicativas, mencionadas no projeto, afetam a variação da medida da rentabilidade.
Os resultados do estudo demonstram que ser B Corp tem um impacto significativo na variância da geração de fundos, o que significa que ser B Corps pode afetar a rentabilidade da empresa e, ao fazê-lo, gera valor junto dos seus “stakeholders”.
This study contributes to a deeper understanding of the organizational sustainable development in a stakeholder perspective. A topical issue that has been more present in the political 2030 Agenda of the United Nations. The investigation studies in particular companies that undergo Environmental, Social and Governance practices by the name of B Corps, which are engaged in social and environmental activities, with a “Profit for Purpose” mission, to generate value alongside stakeholders, and how these organizations positively impact the pharmaceutical industry. In the present research, we perform a literature review that dives in on the importance of Corporate Social responsibility practices in organizations, using pharmaceutical B Corps in the Iberian Peninsula as a conduit for organizations to understand how they can operate within the pharmaceutical industry, balancing their profit and sustainable development goals, to create value. Complementing our Literature review, we perform quantitative study with a series of statistical regression tests that look to understand how B Corp and other explanatory variables, mentioned in the project, affect the variance of the measure of profitability. Our study findings contribute to the fact that B Corp does have a significant impact on the variance of fund generation, meaning that B Corps can affect the profitability of the company and while doing so, generating value with its stakeholders.
This study contributes to a deeper understanding of the organizational sustainable development in a stakeholder perspective. A topical issue that has been more present in the political 2030 Agenda of the United Nations. The investigation studies in particular companies that undergo Environmental, Social and Governance practices by the name of B Corps, which are engaged in social and environmental activities, with a “Profit for Purpose” mission, to generate value alongside stakeholders, and how these organizations positively impact the pharmaceutical industry. In the present research, we perform a literature review that dives in on the importance of Corporate Social responsibility practices in organizations, using pharmaceutical B Corps in the Iberian Peninsula as a conduit for organizations to understand how they can operate within the pharmaceutical industry, balancing their profit and sustainable development goals, to create value. Complementing our Literature review, we perform quantitative study with a series of statistical regression tests that look to understand how B Corp and other explanatory variables, mentioned in the project, affect the variance of the measure of profitability. Our study findings contribute to the fact that B Corp does have a significant impact on the variance of fund generation, meaning that B Corps can affect the profitability of the company and while doing so, generating value with its stakeholders.
Description
Keywords
CSR SDG B Corps Pharmaceutical Industry Stakeholders